Key result
Statin-induced dermatomyositis can mimic rhabdomyolysis and persists despite drug cessation and hydration.
Why the study?
How can statin-induced dermatomyositis be distinguished from statin-induced myopathy or rhabdomyolysis?
Case Report (n=1)
How can statin-induced dermatomyositis be distinguished from statin-induced myopathy or rhabdomyolysis?
Answers are grounded in this paper and cite their sources.
Persistent myopathy symptoms after statin withdrawal should prompt investigation for immune-mediated complications like dermatomyositis.
Statin-induced dermatomyositis is a rare immune-mediated complication that may mimic rhabdomyolysis early in its presentation.Lack of clinical or biochemical improvement after statin withdrawal and intravenous hydration should raise suspicion for inflammatory myopathy.Cutaneous findings, seronegative myositis profile, and skin biopsy features are key to distinguishing dermatomyositis from necrotizing autoimmune myopathy.
No takes yet. Share an insight, caveat, or question.
Pastrana-Echevarria et al. (2026) conducted a case report in Dermatomyositis mimicking statin-induced myopathy (n=1). Statin was evaluated. Statin-induced dermatomyositis may mimic rhabdomyolysis and should be suspected when patients fail to improve after statin withdrawal and intravenous hydration.
Synapse has enriched 10 related papers. Consider them for comparative context: